| Type | Title | Date Released | |
|---|---|---|---|
4 | Sonnenschein Elazar (Reporting) | ||
4 | Woods David (Reporting) | ||
4 | Guz-Lavi Racheli (Reporting) | ||
3 | Woods David (Reporting) | ||
6-K | Pulsenmore Appoints David Woods as Chief Commercial Officer to Accelerate U.S. Growth | ||
SCHEDULE 13G | Aquamarine Financial (Cayman) Ltd (Filed by) | ||
6-K | Pulsenmore Expands Its Fertility Platform into the UK with MHRA Registration | ||
6-K | Pulsenmore Completes CE European Registration for Home Ultrasound System for Fertility Care | ||
EFFECT | Form EFFECT | ||
POS AM | SHARE RESALE REGISTRATION | Shares: 2,239,500 EFFECTIVE, DATED 2026-09-01 | ||
S-8 | Form S-8 | ||
6-K | Pulsenmore Ltd. Condensed Consolidated Interim Financial Statements for the Period Ended June 30, 2026 |
